From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.15
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.69
Pain Relevance 0.21

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

biosynthetic process (ACCS)
Anatomy Link Frequency
heart 2
ACCS (Homo sapiens)
Pain Link Frequency Relevance Heat
Angina 11 77.32 Quite High
ischemia 7 70.00 Quite High
Inflammation 11 50.48 Quite High
imagery 1 11.44 Low Low
cytokine 3 10.00 Low Low
metalloproteinase 6 5.00 Very Low Very Low Very Low
Bioavailability 3 5.00 Very Low Very Low Very Low
Inflammatory response 2 5.00 Very Low Very Low Very Low
Inflammatory marker 1 5.00 Very Low Very Low Very Low
cva 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Acute Coronary Syndrome 70 100.00 Very High Very High Very High
Hemorrhage 17 98.00 Very High Very High Very High
Natriuresis 1 97.24 Very High Very High Very High
Renal Failure 2 95.76 Very High Very High Very High
Anaemia 1 94.24 High High
Myocardial Infarction 23 91.48 High High
Death 12 88.16 High High
Cv General 3 Under Development 9 77.68 Quite High
Cv Unclassified Under Development 7 70.00 Quite High
Vascular Disease 1 67.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Many studies have been shown that elevation of BNP as well as NT-proBNP levels obtained after the acute phase (median, 40 to 72 hours after symptoms onset) in patients with a broad range of ACS independently predicts mortality.17–19 However, in most of the reports, authors do not distinguish subjects with low ejection fraction and LV enlargement; in all studies, BNP levels appear related to increase of heart failure, predicting of cardiac remodeling and pump dysfunction.
Positive_regulation (elevation) of Positive_regulation (range) of ACS in heart associated with acute coronary syndrome and myocardial infarction
1) Confidence 0.15 Published 2006 Journal Biomark Insights Section Body Doc Link PMC2716777 Disease Relevance 1.09 Pain Relevance 0.21
Finally, the ESC guidelines for the management of NSTE-ACS accord particular attention to patients at high risk of bleeding, namely women, elderly patients, patients with renal failure and those with baseline anemia.
Positive_regulation (accord) of Positive_regulation (management) of NSTE-ACS associated with acute coronary syndrome, anaemia, renal failure and hemorrhage
2) Confidence 0.06 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2856573 Disease Relevance 0.59 Pain Relevance 0

General Comments

This test has worked.

Personal tools